Description
A tumor-inhibiting antibiotic that inhibits the glutamine-dependent amidotransferases involved in nucleotide biosynthesis, N-formylglycineamidine ribotide synthetase and glucosamine-6-phosphate isomerase; also inhibits the hexosamine biosynthetic pathway, which has been shown to protect against hyperglycemic endothelial damage
Formal name: O-(2-diazoacetyl)-L-serine
Synonyms: CI-337|CN 15757|NSC 742|O-Diazoacetyl-L-serine
Molecular weight: 173.1
CAS: 115-02-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Microbial Metabolites||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cancer|Metabolism||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes